ALLMedicine™ Skull Base Tumors Center
Research & Reviews 206 results
https://doi.org/10.1002/pbc.30165
Pediatric Blood & Cancer; Intrapiromkul J, Wangaryattawanich P et. al.
Dec 25th, 2022 - A standardized imaging protocol for pediatric oncology patients is essential for accurate and efficient imaging, while simultaneously promoting collaborative understanding of pathologies and radiologic assessment of treatment response. The objecti...
https://clinicaltrials.gov/ct2/show/NCT03759717
Dec 6th, 2022 - The overall goal of this proposal is to determine new molecular and cellular features that define tumor subtypes that are clinically actionable, may drive important changes in patient management, and/or elucidate novel chemotherapeutic options. Sk...
https://clinicaltrials.gov/ct2/show/NCT04374448
Nov 14th, 2022 - The investigators aim to evaluate the effectiveness and feasibility of using a fluorescent dye, Indocyanine Green (ICG), in endoscopic sinus, skullbase, sinus tumor resection, or posterior epistaxis surgery. Adults 19 years or older, seen in the P...
https://clinicaltrials.gov/ct2/show/NCT04265430
Oct 27th, 2022 - PRIMARY OBJECTIVES: I. Demonstrate the feasibility of serial magnetic resonance (MR) imaging biomarkers for assessment of early, intermediate, and late radiotherapy-attributable physiologic alteration of tumor and normal tissues and the kinetics t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489402
Contrast Media & Molecular Imaging; Fang D, Yang C et. al.
Sep 27th, 2022 - To explore the effect of CT/MRI image fusion on cerebrovascular protection, postoperative complications and limb function recovery in patients with anterior and middle skull base tumors. During January 2019 to December 2021, a retrospective study ...
Clinicaltrials.gov 8 results
https://clinicaltrials.gov/ct2/show/NCT03759717
Dec 6th, 2022 - The overall goal of this proposal is to determine new molecular and cellular features that define tumor subtypes that are clinically actionable, may drive important changes in patient management, and/or elucidate novel chemotherapeutic options. Sk...
https://clinicaltrials.gov/ct2/show/NCT04374448
Nov 14th, 2022 - The investigators aim to evaluate the effectiveness and feasibility of using a fluorescent dye, Indocyanine Green (ICG), in endoscopic sinus, skullbase, sinus tumor resection, or posterior epistaxis surgery. Adults 19 years or older, seen in the P...
https://clinicaltrials.gov/ct2/show/NCT04265430
Oct 27th, 2022 - PRIMARY OBJECTIVES: I. Demonstrate the feasibility of serial magnetic resonance (MR) imaging biomarkers for assessment of early, intermediate, and late radiotherapy-attributable physiologic alteration of tumor and normal tissues and the kinetics t...
https://clinicaltrials.gov/ct2/show/NCT03972514
Jul 8th, 2022 - Brain injury is a known complication of cranial RT, but little is known about the factors that predispose patients to such injury. The brain is a highly interconnected organ linked through neuronal connections, cellular migration, and vascular sup...
https://clinicaltrials.gov/ct2/show/NCT04222309
Jun 22nd, 2022 - Laparoscopically harvested omental free flaps are commonly used to fill surgical cavities after resection of head and neck cancers. The investigators hypothesize that a laparoscopically harvested omental free flap in our patients with resected rec...
News 1 results
https://www.onclive.com/view/viviane-tabar-md-named-chair-of-the-department-of-neurosurgery-at-memorial-sloan-kettering-cancer-center
Dec 20th, 2020 - Viviane Tabar, MD, has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair f...
